Fiona E. McRonald - Concepedia

Concepedia

Author

Fiona E. McRonald

University of Liverpool ORCID

Also Known As

C. Jenkins, F E McRonald, F McRonald, F. E McRonald, F. McRonald, Fiona E McRonald, Fiona E. McRonald, Fiona E. Mcronald, Fiona McRonald, Fiona E. McRonald

64

Publications

3.3K

Citations

21

H-Index

34

Concepts

All Affiliations

University of Liverpool Institute of Cancer Research University of Cambridge Queen Mary University of London National Cancer Registration Service

FE

About

Fiona E. McRonald is an author at University of Liverpool specializing in medicine, pathology, and genetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.2K
2	Cell Biology	2	2	76
3	Natural Sciences	1	1	26
4	Biochemistry	1	1	50
5	Immunology	1	1	50

Fiona E. McRonald

×

27

Publications

3.3K

Citations

21

H-Index

	Year	Citations
Lung adenocarcinoma promotion by air pollutants William Hill, Emilia L. Lim, Clare E. Weeden, Nature AsthmaLung DepositionEnvironmental Lung DiseasesLung InflammationRespiratory Toxicology	2023	663
Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial John Burn, Harsh Sheth, Faye Elliott, The Lancet	2020	385
UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening John K. Field, Stephen W. Duffy, David Baldwin, Thorax	2015	333
The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer John K. Field, Stephen W. Duffy, David Baldwin, Health Technology Assessment	2016	274
Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis John K. Field, Daniel Vulkan, Michael P.A. Davies, The Lancet Regional Health - Europe	2021	209
RHBDF2 Mutations Are Associated with Tylosis, a Familial Esophageal Cancer Syndrome Diana C. Blaydon, Sarah Etheridge, Janet M. Risk, The American Journal of Human Genetics Somatic VariantEsophageal CancerGenetic DisorderMedicineGenetics	2012	200
Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial Noor Khalili Mohd Ali, Kate Lifford, Ben Carter, BMJ Open	2015	197
Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma Mark R. Morris, Christopher J. Ricketts, Dean Gentle, Oncogene UrologyGenitourinary CancerEpigenetic ChangeEpigenomicsCancer Genomics	2010	194
The UK Lung Screen (UKLS): Demographic Profile of First 88,897 Approaches Provides Recommendations for Population Screening Fiona E. McRonald, Ghasem Yadegarfar, David Baldwin, Cancer Prevention Research	2014	127
Long-term psychosocial outcomes of low-dose CT screening: results of the UK Lung Cancer Screening randomised controlled trial Kate Brain, Kate Lifford, Ben Carter, Thorax	2016	91

Page 1